Advanced Life Sciences Holdings, Inc. (ADLS.OB)
0.17USD
23 Dec 2009
$0.00 (+0.00%)
$0.17
$0.17
$0.18
$0.17
414,646
1,425,906
$1.62
$0.14
ADLS.OB
About
Overall
| Beta: | 3.40 |
| Market Cap (Mil.): | $13.67 |
| Shares Outstanding (Mil.): | 78.12 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ADLS.OB | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 3.57 | 4.64 |
| EPS (TTM): | 67.83 | -- | -- |
| ROI: | -- | 1.79 | 2.82 |
| ROE: | -- | 2.40 | 3.58 |
U.S. FDA advisory meetings through Aug 4
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 30
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
U.S. FDA advisory meetings through June 3
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT.
UPDATE 1-Advanced Life Q4 loss narrows; cuts 30 pct jobs
* To take $60,000 Q1 charge, sees $1 mln annual savings
UPDATE 1-Advanced Life, Wyeth unit in pact for pneumonia drug
Oct 1 (Reuters) - Advanced Life Sciences Holdings Inc said a unit of Wyeth bought a 4.9 percent stake in the biopharmaceutical company as part of an agreement related to antibiotic cethromycin, sending its shares up 36 percent.
Competitors
| Price | Change | |
|---|---|---|
| Sanofi-Aventis SA (SASY.PA) | €55.60 | -0.05 |
| Pfizer Inc. (PFE.N) | $18.58 | -0.03 |
| GlaxoSmithKline plc (GSK.L) | £1,322.00 | +2.00 |
| Johnson & Johnson (JNJ.N) | $64.57 | +0.04 |
| Abbott Laboratories (ABT.N) | $54.09 | -0.03 |
| Bristol Myers Squibb Co. (BMY.N) | $25.70 | +0.11 |
| Bristol Myers Squibb Co. (BMY_p.N) | $440.00 | 0.00 |
| Oscient Pharmaceuticals Corporation (OSCIQ.PK) | $0.04 | -0.00 |
| Bayer AG (BAYGn.DE) | €55.82 | +0.39 |
| Bayer AG (BAYE.F) | -- | -- |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
